The Healthcare IT Symposium:
The Role of Technology Innovation in Healthcare
In Partnership with:

    

Updates from the Event

Event Photos: Presentations: Jaap Suermondt Presentation Slides Lonne Jaffe Presentation Slides Articles: Reuters Article Newswire Article Yahoo Finance Article Fox Business Article Marketwire Article DJ Cline Article James Downey Article

Description:
SDForum is pleased to hold its first ever symposium on Healthcare information technology in partnership with IBM. This high level half-day symposium will take a critical look at the key issues and opportunities facing the health care industry today as it struggles to catch up in its IT infrastructure and respond to new regulations. 

While information technology is without a doubt critical to the success of efficient and economic delivery of health care, the industry is lagging behind.  While access to vital information is essential, health care providers also must conform to the requirements of HIPAA (Health Insurance Portability and Accountability Act). In Silicon Valley, a globally recognized heartland of innovation in technology, what's happening to respond to this need and what are the challenges involved in getting up to speed? Who are the stars amd what's next in healthcare information technology?

Agenda with Confirmed Speakers:  

Online Pricing:
$90 SDForum Members; $110 Non-members; $45 Platinum Pass.
Price is $25 more at the door

There are a few sponsorship opportunities still left! Click here for more information.

Twitter with us: @SDForum, #SDFHealth

Thanks to our Host Sponsor:

  







    Thank you to our organizing committee:
AJ Chen
Abhishek Gattani, Kosmix
Gamiel Gran, Sierra Ventures
Lennart Frantzell, IBM
Robert Lasater
Deborah Magid, IBM
Steve Mezak, Accelerance
Tom Thomas, Pillsbury Winthrop

Speakers:
Brian Ascher, Partner, Venrock. Brian joined Venrock in 1998 as a Kauffman Fellow, after holding marketing and product marketing positions at Intuit, Inc.  He had responsibility for launching several versions of the market-leading software product Quicken and the Quicken.com website. The job led to a passion for the user experience for Brian, one that he continually applies to consumer and software ventures.  He also brings strategy skills gained at the Monitor Group and investment banking deal experience from Robertson, Stephens & Company to his portfolio companies. In 2009, Brian was named to Forbes' Midas List, which ranks the top venture capitalists in technology and life sciences and was chosen as an Always On VC100 for the VCs who have backed the most profitable winners in the last four years.

Adam Bosworth, Founder, President & CEO, Keas. Adam started and runs Keas, a company dedicated to getting people the personalized advice and information they need to best manage their health. Before that he started and ran Google Health and before that ran engineering for various Google projects including gmail, calendar, spreadsheets, picassa, blogger. Before that built Access, XML and IE 4.0 for Microsoft and Workshop, Portal, and Integration for BEAS systems.

Jeff Calcagno, Principal, Scale Venture Partners. Jeff is a physician and a Principal & Kauffman Fellow at Scale Venture Partners, a leading technology and healthcare venture fund. Previously, he held senior leadership roles in both life sciences and wireless software companies.  He also served as a healthcare analyst at JPMorgan H&Q and as a management consultant at McKinsey & Company.  Jeff received his A.B. and M.D. from Harvard University where he was a Rotary Scholar.  He completed residency training in psychiatry at UCLA.

Linda Drumright, President and COO of DecisionView, Inc. Linda brings 27 years experience in building commercial enterprise software, developing new markets, serving customers and scaling organizations. Before joining DecisionView 5 years ago, Linda delivered several market-leading solutions for companies like DigitalThink, Hyperion Solutions, Arbor Software, Sybase, Tolerant Systems and even IBM (as an intern many, many summers ago).

Gerry Hinkley, Co-Chair of the Health Care Industry Team, Pillsbury Winthrop Shaw Pittman LLP.  Gerry’s HIT practice is focused on ARRA-HITECH implementation, community network development and finance, network user participation, system procurement, regulatory compliance and privacy.  Gerry has been involved with governance, network user and privacy projects for Markle Connecting for Health and eHealth Initiative as well as numerous health information exchange organizations.  He serves as a member of the Steering Group of Markle Connecting for Health, the HIMSS Legal Aspects Task Force and the Leadership Council of eHealth Initiative, and as a Legal Columnist for HIMSS HIE Lights.

Ryan Howard, Founder and CEO, Practice Fusion.  With an extensive background in SaaS, health IT and venture capital,Ryan founded Practice Fusion in 2005; creating an EMR system vastly different from anything else on the market and with the potential to fundamentally improve US healthcare. The company grew rapidly as a free and web-based EMR targetted toward physician practices in a market dominated by expensive legacy systems. Today, Practice Fusion has over 40,000 users across the country and is the fastest-growing Electronic Medical Record (EMR) community in the US.

Lonne A. Jaffe, Director, Public Sector Solutions, IBM Software
Lonne is the executive responsible for the government, education, healthcare and life sciences solutions business for IBM, including the Health Integration Framework, the Government Industry Framework, and the Government Network Centric Operations Framework for defense and intelligence. Lonne received his Bachelor's and Master's degrees from Harvard University, and before joining IBM he held positions at Microsoft, Sony, and Goldman Sachs.

Dr. Ron Jimenez, Associate Medical Director, Clinical Informatics, Santa Clara Valley Health and Hospital System. Dr. Jimenez, a former CalRHIO Board Member for 3 years, has been a practicing pediatrician for 20+ years in Silicon Valley and holds a Clinical Assistant Professor, Affiliated, appointment with the Stanford University School of Medicine. He is a graduate of the University of Southern California (USC) Keck School of Medicine, interned at Los Angeles County + USC Medical Center and completed his Pediatric Residency at the UCSF Program in Fresno, California. He joined a private practice soon after residency and is currently the Associate Medical Director, Clinical Informatics at the Santa Clara Valley Health and Hospital System and Santa Clara Valley Medical Center, the public hospital for Silicon Valley. He has held this office for 10 years. He holds a Certificate in Medical Informatics from Oregon Health and Science University (OHSU). Dr.
Jimenez currently sits on the Cal eConnect Board.

Philip Korn, Managing Director, Venture Capital, TriNet
Philip joined TriNet in May 2009 and leads TriNet’s venture capital relationship efforts nationwide.  Venture capital firms and their portfolio companies are TriNet’s core market focus and TriNet has 10-15% market share of all venture backed companies.  Philip is responsible for business development and is establishing a venture relationship program for TriNet that will help drive the company’s growth in the coming years.  Philip has an MBA from Thunderbird School of Global Management and a BS in Business Administration from the University of Maryland, College Park.

Dr. Louis G. Lange, M.D., PhD, Partner, Asset Management
Dr. Lange has 22 years experience in academic medicine at Harvard and Washington University, where he served as Chief of Cardiology and Professor of Medicine at Jewish Hospital from 1985-1992 and was one of the first academicians in molecular cardiology.  He founded CV Therapeutics based on this broad field and as Chairman, CEO and Chief Scientific Officer, led the IPO in 1996 and the overall pipeline development and the initiatives for US FDA and European EMEA approval for Ranexa®, a first-in-class late sodium channel blocker and the first anti-anginal drug class approved in 30 years in the US. He also led the approval of Lexiscan®, a first-in-class adenosine A2a receptor agonist for use in myocardial perfusion imaging studies. Dr. Lange oversaw the commercial success of CV Therapeutics and its sale to Gilead in 2009 for $1.4 billion dollars.

Dr. Wayne Pan, MD, PhD, MBA, Senior Managing Partner, SciMed Partners.
Dr. Pan is currently Senior Managing Partner at SciMed Partners, a boutique consulting firm specializing in helping companies commercialize innovation in emerging technologies, medical devices, biotechnology, and pharmaceuticals. He has also been involved with several local healthcare-related web 2.0 start-ups, providing clinical as well as marketing strategy support. He earned his undergraduate degree in biology from The Johns Hopkins University. He holds an MD from Mt. Sinai
School of Medicine, New York University; a PhD in Physiology, from the Graduate School of Biomedical Sciences, City University of New York and an MBA from The Wharton School, University of Pennsylvania. In addition to his role with SciMed, he is adjunct faculty at The Wharton School.

Marco Smit, President, Health 2.0 Advisors. Marco has more than 16 years experience helping companies in the US, Europe, and Asia win. He has worked with large companies in leading management consulting firms (Monitor Company, Bain, A.T. Kearney), as well as in executive roles with smaller companies in industry (e.g. Affymetrix). He especially enjoys working in the areas of growth strategy, sales & marketing effectiveness, business development and M&A. Marco is the President of Health 2.0 Advisors.

Jaap Suermondt, Director, HP Labs
Jaap is the Director of the Business Optimization Lab at HP Labs, leading a group of researchers and managers in analytics with expertise in data mining and the decision sciences, operations research, algorithms, statistics, marketing science and economics. He has a bachelor of science in mathematical and computational science from Stanford University and a master of science and Ph.D. in medical information sciences from Stanford University School of Medicine. He is inventor or co-inventor on over 50 filed patent applications, with 27 patents granted so far.